These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2054 related articles for article (PubMed ID: 25448878)

  • 1. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
    Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
    Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.
    Shoshan-Barmatz V; Golan M
    Curr Med Chem; 2012; 19(5):714-35. PubMed ID: 22204343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress.
    Shoshan-Barmatz V; Maldonado EN; Krelin Y
    Cell Stress; 2017 Oct; 1(1):11-36. PubMed ID: 30542671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDAC1: from structure to cancer therapy.
    Shoshan-Barmatz V; Mizrachi D
    Front Oncol; 2012; 2():164. PubMed ID: 23233904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
    Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
    Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
    J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
    J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An N-terminal nucleotide-binding site in VDAC1: involvement in regulating mitochondrial function.
    Yehezkel G; Abu-Hamad S; Shoshan-Barmatz V
    J Cell Physiol; 2007 Aug; 212(2):551-61. PubMed ID: 17503466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
    Aram L; Geula S; Arbel N; Shoshan-Barmatz V
    Biochem J; 2010 Apr; 427(3):445-54. PubMed ID: 20192921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
    Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
    J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
    J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.